Chronic Widespread Pain in HIV: Novel Mechanisms and Therapeutics
Status:
Not yet recruiting
Trial end date:
2024-12-30
Target enrollment:
Participant gender:
Summary
To determine if decreased production or release of endogenous opioid peptides by peripheral
immune cells contributes to hypersensitivity in people with HIV